Misook Yu

Array ( [id] => 13717273 [patent_doc_number] => 20170369591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-28 [patent_title] => PREDICTIVE MARKER FOR TOPOISOMERASE I INHIBITORS [patent_app_type] => utility [patent_app_number] => 15/474156 [patent_app_country] => US [patent_app_date] => 2017-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43702 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15474156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11837747 [patent_doc_number] => 20170219465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-03 [patent_title] => 'Methods and Compositions for Preparing Biological Specimens for Microscopic Analysis' [patent_app_type] => utility [patent_app_number] => 15/431388 [patent_app_country] => US [patent_app_date] => 2017-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 21054 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15431388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16688399 [patent_doc_number] => 20210070875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => ANTI-C5AR ANTIBODY AND PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/965209 [patent_app_country] => US [patent_app_date] => 2017-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13427 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11436118 [patent_doc_number] => 20170037139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-09 [patent_title] => 'TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA WITH ANTI-CD20 ANTIBODY' [patent_app_type] => utility [patent_app_number] => 15/334234 [patent_app_country] => US [patent_app_date] => 2016-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4233 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15334234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11348926 [patent_doc_number] => 20160367666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'SELF-BUFFERING PROTEIN FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 15/255018 [patent_app_country] => US [patent_app_date] => 2016-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 31301 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15255018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12832243 [patent_doc_number] => 20180169253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => Means and Methods for Treatment of B-Cell Malignancies [patent_app_type] => utility [patent_app_number] => 15/579312 [patent_app_country] => US [patent_app_date] => 2016-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13847 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10996417 [patent_doc_number] => 20160193359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/052655 [patent_app_country] => US [patent_app_date] => 2016-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 122650 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15052655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10797866 [patent_doc_number] => 20160144023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'DRY SOLID ALUMINUM ADJUVANT-CONTAINING VACCINES AND RELATED METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/941323 [patent_app_country] => US [patent_app_date] => 2015-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 43576 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14941323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10657687 [patent_doc_number] => 20160003831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'ANALYSIS METHOD FOR ASSESSING STAGE OF PROSTATE CANCER, PROSTATE-CANCER STAGE ASSESSMENT METHOD, PROSTATE-CANCER DETECTION METHOD, AND TEST KIT' [patent_app_type] => utility [patent_app_number] => 14/857088 [patent_app_country] => US [patent_app_date] => 2015-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12836 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14857088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10699467 [patent_doc_number] => 20160045614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'TARGETED LIPOSOMAL COMPOSITION USING ANTI-HER-2 AFFIBODY MOLECULES AND APPLICATIONS THEREOF IN CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/827478 [patent_app_country] => US [patent_app_date] => 2015-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5416 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14827478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11728107 [patent_doc_number] => 20170189549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'Payload-Polymer-Protein Conjugates' [patent_app_type] => utility [patent_app_number] => 15/317989 [patent_app_country] => US [patent_app_date] => 2015-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 33327 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10483334 [patent_doc_number] => 20150368353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-24 [patent_title] => 'Anti-Podoplanin Antibodies and Methods of Use' [patent_app_type] => utility [patent_app_number] => 14/726959 [patent_app_country] => US [patent_app_date] => 2015-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13491 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14726959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11129290 [patent_doc_number] => 20160326266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-10 [patent_title] => 'Chemically-Locked Bispecific Antibodies' [patent_app_type] => utility [patent_app_number] => 14/708273 [patent_app_country] => US [patent_app_date] => 2015-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3919 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14708273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11707945 [patent_doc_number] => 20170176445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'METHOD FOR DETERMINING THE LEVEL OF HYPOXIA IN A TUMOR' [patent_app_type] => utility [patent_app_number] => 15/118397 [patent_app_country] => US [patent_app_date] => 2015-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7436 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15118397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10201558 [patent_doc_number] => 20150086545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'COMBINATION THERAPY OF HER EXPRESSING TUMORS' [patent_app_type] => utility [patent_app_number] => 14/558606 [patent_app_country] => US [patent_app_date] => 2014-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 55856 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14558606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11032962 [patent_doc_number] => 20160229918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'TUMOR SELECTIVE ANTIBODIES SPECIFIC TO ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR PROTEIN' [patent_app_type] => utility [patent_app_number] => 14/904312 [patent_app_country] => US [patent_app_date] => 2014-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24865 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14904312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10685741 [patent_doc_number] => 20160031887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/774531 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59355 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10467178 [patent_doc_number] => 20150352193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'SELECTIVE GLYCOSIDASE REGIMEN FOR IMMUNE PROGRAMMING AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/760809 [patent_app_country] => US [patent_app_date] => 2014-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11804 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14760809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10443298 [patent_doc_number] => 20150328310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-19 [patent_title] => 'METHODS AND COMPOSITIONS RELATING TO TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/652363 [patent_app_country] => US [patent_app_date] => 2013-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16634 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14652363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10408096 [patent_doc_number] => 20150293104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'EPITHELIAL OVARIAN CANCER DIFFERENTIATION MARKER' [patent_app_type] => utility [patent_app_number] => 14/413846 [patent_app_country] => US [patent_app_date] => 2012-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15835 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413846 [rel_patent_id] =>[rel_patent_doc_number] =>)